Protagonist Therapeutics Inc

NASDAQ:PTGX   2:27:37 PM EDT
28.14
-1.19 (-4.06%)
Products

Protagonist Therapeutics Receives FDA Breakthrough Therapy Designation For Rusfertide In Polycythemia Vera

Published: 06/03/2021 12:04 GMT
Protagonist Therapeutics Inc (PTGX) - Protagonist Therapeutics Receives FDA Breakthrough Therapy Designation for Rusfertide in Polycythemia Vera.